A Randomized Controlled Phase 2 Study of Neoadjuvant Eribulin Versus Paclitaxel in Women with Operable Breast Cancer: The JONIE-3 Study

Autor: Narui, Kazutaka, Miura, Daishu, Hasegawa, Yoshie, Tachibana, Akihiko, Horiguchi, Jun, Hayashi, Mitsuhiro, Miyashita, Masaru, Kubota, Tomoyuki, Suzuki, Masato, Yamada, Kimito, Yamada, Akimitsu, Akazawa, Kohei, Kohno, Norio, Ishikawa, Takashi
Zdroj: In Clinical Breast Cancer December 2022 22(8):e881-e891
Databáze: ScienceDirect